The CCR6–CCL20 axis promotes regulatory T cell glycolysis and immunosuppression in tumors

Pant, Ayush;Jain, Aanchal ;Chen, Yiyun;Patel, Kisha;Saleh, Laura;Tzeng, Stephany;Nitta, Ryan;Zhao, Liang;Wu, Caren;Bederson, Maria;Wang, William;Bergsneider, Brandon;Choi, John;Medikonda, Ravi;Verma, Rohit;Cho, Kwang;Kim, Lily;Kim, Jennifer;Yazigi, Eli;Lee, Si Yeon;Rajendran, Sakthi;Rajappa, Prajwal;Mackall, Crystal;Li, Gordon;Tyler, Betty;Brem, Henry;Pardoll, Drew;Lim, Michael;Jackson, Christopher

Description

Data accompanying the manuscript "The CCR6–CCL20 axis promotes regulatory T cell glycolysis and immunosuppression in tumors"-- includes RNA-Seq of sorted murine Tregs from WT and Ccr6 KO mice. The experiment was designed to compare transcriptomic differences between WT and Ccr6 KO Tregs during activation. WT and Ccr6 KO Tregs, cells were isolated from mice and cultured in vitro for 3 days with activation using anti-CD3/CD28 beads. Total RNA was extracted using the Trizol method. Quantity and quality were assessed using a Thermo Scientific™ NanoDrop™ 2000/2000c Spectrophotometer. Novogene Corporation Inc prepared the RNA-seq 250-300 bp insert cDNA library. Illumina HiSeq platform PE150 sequencing was used for sequencing, yielding 20M raw reads/sample. Mus Musculus mm39 was used as the reference genome for alignment.

Citations (0)

Mentions (0)

Metrics

Dataset Index

0.4

FAIR Score

65%

Citations

0

Mentions

0

Metrics Over Time

Publication Details

DOI

Publisher

Mendeley Data

License

Creative Commons Attribution 4.0 International

Assigned Domain

Subfield

Molecular Biology

Field

Biochemistry, Genetics and Molecular Biology

Domain

Life Sciences

Confidence Score

47%

Source

Scholar Data Model

Keywords

ImmunologyFOS: Clinical medicineCancer Immunology

Normalization Factors

FT

53.85

CTw

1.00

MTw

1.00